All lobbying filings

VANTIVE US HEALTHCARE LLC

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $590,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 4441
Patient Access to Innovative New Technologies Act of 2025

Lobbying activity 4

Medicare/Medicaid

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act

Health Issues

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring

Foreign Relations

Issues related to U.S. global assistance programs.

Trade (domestic/foreign)

Issues related to tariffs. Reaching out to establish contacts with US embassy teams in certain countries.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.